Vericel Corporation (VCEL): Price and Financial Metrics

VCEL POWR Grades

• Quality is the dimension where VCEL ranks best; there it ranks ahead of 74.07% of US stocks.
• VCEL's strongest trending metric is Quality; it's been moving up over the last 177 days.
• VCEL's current lowest rank is in the Value metric (where it is better than 19.61% of US stocks).

VCEL Stock Summary

• Price to trailing twelve month operating cash flow for VCEL is currently 77.58, higher than 95.27% of US stocks with positive operating cash flow.
• VCEL's price/sales ratio is 8.35; that's higher than the P/S ratio of 86.91% of US stocks.
• In terms of twelve month growth in earnings before interest and taxes, VERICEL CORP is reporting a growth rate of 106.15%; that's higher than 87.25% of US stocks.
• If you're looking for stocks that are quantitatively similar to VERICEL CORP, a group of peers worth examining would be YOU, FTCI, AUID, ENFN, and HYZN.
• Visit VCEL's SEC page to see the company's official filings. To visit the company's web site, go to vcel.com.

VCEL Valuation Summary

• In comparison to the median Healthcare stock, VCEL's EV/EBIT ratio is 1427.27% lower, now standing at -87.6.
• Over the past 243 months, VCEL's EV/EBIT ratio has gone down 86.6.

Below are key valuation metrics over time for VCEL.

VCEL Growth Metrics

The 4 year net cashflow from operations growth rate now stands at 87.81%.
• Its 3 year net cashflow from operations growth rate is now at 3481.9%.
• Its year over year price growth rate is now at -45.13%.

Over the past 34 months, VCEL's revenue has gone up $41,647,000.

The table below shows VCEL's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-12-31	164.365	17.687	-16.709
2022-09-30	159.262	21.263	-18.096
2022-06-30	155.217	20.796	-16.45
2022-03-31	157.69	22.422	-11.273
2021-12-31	156.184	29.04	-7.471
2021-09-30	153.822	29.826	0.214

VCEL's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• VCEL has a Quality Grade of C, ranking ahead of 72.89% of graded US stocks.
• VCEL's asset turnover comes in at 0.761 -- ranking 35th of 682 Pharmaceutical Products stocks.
• TCON, NMTR, and PTCT are the stocks whose asset turnover ratios are most correlated with VCEL.

The table below shows VCEL's key quality metrics over time.